Chubu-Rosai Hospital

Nagoya, Aichi-ken 455-8530

1 studies enrolling now · 8 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Alzheimer Disease, Arthritis, Atherosclerotic Cardiovascular Disease, Autoimmune Diseases, Chronic Kidney Disease, Connective Tissue Diseases, Diabetic Gastroparesis, High-risk Transient Ischemic Attack, Idiopathic Gastroparesis, Immune System Diseases, Joint Diseases

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease — Completed
• A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease — Completed
• A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis — Stopped early
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis — Completed
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed